View Post

Konan University team effectively curbs production of cancer-linked protein

In In The News by Barbara Jacoby

From: japantimes.co.jp A research team at Konan University in the city of Kobe has developed an effective photodynamic cancer therapy, which specifically targets a protein that facilitates tumor growth and metastasis. As abnormal functioning of proteins in the so-called RAS family has been known for causing cancer, therapies targeting RAS have been thought to be a potentially effective approach. However, due …

View Post

Targeting the engine room of the cancer cell

In In The News by Barbara Jacoby

Source:: Columbia University Irving Medical Center From: sciencedaily.com Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them. The study, published today on Nature Genetics, by Dr. Andrea Califano of Columbia University Irving Medical …

View Post

How could designer proteins thwart cancer?

In In The News by Barbara Jacoby

By: Maria Cohut From: medicalnewstoday.com Chromosomes, or DNA molecules found in cells carrying genetic material, are “bookended” by telomeres, which will prevent them from “unraveling.” Telomeres are also important in the growth and aging process of cells, but what happens when cancer “hijacks” them, and can this be prevented? “A normal cell grows for just the right amount of time that …

View Post

New Blood Test May Detect Multiple Types of Cancer at Earlier Stages

In In The News by Barbara Jacoby

From: healthline.com Screening methods for certain types of cancer, particularly breast cancer and prostate cancer, can lead to early diagnosis. However, there’s no catchall test to screen for every one of the more than 100 types of cancer that exist. Researchers at GRAIL, a Silicon Valley healthcare company, are working on a DNA test based off a simple blood draw that can …

View Post

Gold could be the key to better diagnosis and treatment of leukaemia

In In The News by Barbara Jacoby

Gold could be the key to better diagnosis and treatment of leukaemia Nano-sized particles of gold could hold the key to the better diagnosis and treatment of leukaemia, thanks to ground-breaking research led by a University of Kent scientist. The study, led by Dr Vadim Sumbayev, of the University’s Medway School of Pharmacy (MSP), shows that gold nanoparticles that are …

View Post

It’s not time to freak out that Crispr will cause cancer—yet

In In The News by Barbara Jacoby

By: Katherine Ellen Foley From: qz.com The biotech industry is obsessed with Crispr, the molecular gene-editing technology capable of snipping out undesired bits of genetic material and, sometimes, replacing it with preferred DNA. Theoretically, Crispr capabilities could make curing previously incurable genetic conditions like cystic fibrosis a possibility for the first time. But on Monday (June 11), two new studies published side by sidein Nature Medicine …

View Post

Newman Discusses De-escalating Breast Cancer Surgery

In In The News by Barbara Jacoby

By: Caroline Seymour From: onclive.com In an effort to minimize the extent of surgery, targeted axillary dissection is being explored following surgery in patients with node-positive breast cancer—an exciting precision medicine approach for this population, said Lisa A. Newman, MD. “Full axillary lymph node dissection is an operation that has potential lifelong sequela,” explained Newman. “Every opportunity that we can identify alternatives …

View Post

Gamma Knife™, Immunotherapy Combo Shows Promise in Managing Certain Brain Tumors

In In The News by Barbara Jacoby

With metastatic melanoma cases on the rise, doctors continue to search for effective treatment solutions for controlling brain tumors. Industry-leading San Diego Gamma Knife Center® says therapies combining stereotactic radiosurgery and certain immunotherapies could be the key the medical community has been searching for. Over the past 10 years, diagnoses of new cases of melanoma, the most dangerous form of skin cancer, have …

View Post

STEM CELL TRANSPLANTS EXTEND LIFE FOR MULTIPLE MYELOMA PATIENTS

In In The News by Barbara Jacoby

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure. Using data from two extensive California databases, the team showed median overall survival for transplant patients was around 73 months, while controls who did not receive the procedure lived around 50 …

View Post

Gottlieb at BIO: FDA developing processes around right-to-try law

In In The News by Barbara Jacoby

By: ALARIC DEARMENT From: medcitynews.com Perhaps it was inevitable that with Food and Drug Administration Commissioner Scott Gottlieb speaking before an auditorium full of biotechnology executives, a particularly contentious topic would come up: the new right-to-try law. Gottlieb was at the BIO annual meeting in Boston Thursday for a fireside chat with the organization’s president, Jim Greenwood. During the question-and-answer session, …